Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Rohto Pharmaceutical Co's highest Yield on Cost was 6.59. The lowest was 1.80. And the median was 2.80.
MEX:4527N's 5-Year Yield-on-Cost % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.39 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Rohto Pharmaceutical Co (MEX:4527N) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Rohto Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms
MEX:4527N vs PG, CL, EL: 5-Year Yield-on-Cost % Comparison
For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rohto Pharmaceutical Co 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.
Rohto Pharmaceutical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Rohto Pharmaceutical Co (MEX:4527N) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Rohto Pharmaceutical Co and its competitors. Over the past decade, Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % has ranged from 1.80 to 6.59. According to the industry distribution chart, Rohto Pharmaceutical Co ranks #388 out of 1150 companies in the Consumer Packaged Goods industry, placing it in the top 33.7%.
Is Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % too high?
Rohto Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.80 to a high of 6.59. Based on the distribution chart, Rohto Pharmaceutical Co ranks #388 out of 1150 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Rohto Pharmaceutical Co has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's 5-Year Yield-on-Cost % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Rohto Pharmaceutical Co ranks #388 out of 1150 companies for 5-Year Yield-on-Cost %. This puts Rohto Pharmaceutical Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.39. Historically, Rohto Pharmaceutical Co's own 5-Year Yield-on-Cost % has ranged from 1.80 to 6.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.39, based on 1,150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Rohto Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rohto Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (MEX:4527N) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is MXN368.70, compared to a current price of MXN305.75 — trading 17.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Rohto Pharmaceutical Co's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Rohto Pharmaceutical Co (MEX:4527N), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rohto Pharmaceutical Co (MEX:4527N) Overvalued in 2026?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued.
The current stock price of MXN305.75 is trading 17.1% below its estimated GF Value™ of MXN368.70.
Key valuation signals for MEX:4527N:
5-Year Yield-on-Cost %: 0.00
GF Value™: MXN368.70 vs. price of MXN305.75 (17.1% below fair value)
No single metric tells the full story. See the MEX:4527N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
85GF Score
Get the complete analysis for MEX:4527N
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4527N has been successfully added to your 
